Latest Articles
- Is it safe to continue biologic agents during surgery in patients with inflammatory bowel disease?
Patients taking monoclonal antibodies can continue taking them, but small-molecule drugs should be withheld.
- Denosumab cessation
Bone loss is rapid if patients miss injections. Clinicians can take extra measures to ensure patients get appropriate treatment.